Plasmepsin II–III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum-Reference-Cited by-同舟云学术

Plasmepsin II–III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum

Published:2018-05-02 Issue:1 Volume:9 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Bopp Selina^ORCID,Magistrado Pamela,Wong Wesley,Schaffner Stephen F.^ORCID,Mukherjee Angana,Lim Pharath^ORCID,Dhorda Mehul,Amaratunga Chanaki,Woodrow Charles J.,Ashley Elizabeth A.,White Nicholas J.,Dondorp Arjen M.,Fairhurst Rick M.,Ariey Frederic,Menard Didier,Wirth Dyann F.,Volkman Sarah K.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-018-04104-z.pdf

Reference55 articles.

1. WHO. Methods For Surveillance Of Antimalarial Drug Efficacy WHO Guidelines Approved by the Guidelines Review Committee (2009).

2. Amaratunga, C. et al. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Lancet Infect. Dis. 12, 851–858 (2012).

3. Phyo, A. P. et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet 379, 1960–1966 (2012).

4. Witkowski, B. et al. Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies. Lancet Infect. Dis. 13, 1043–1049 (2013).

5. Ariey, F. et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 505, 50–55 (2014).

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lack of selection of antimalarial drug resistance markers after intermittent preventive treatment of schoolchildren (IPTsc) against malaria in northeastern Tanzania;International Journal of Infectious Diseases;2024-09

2. A Plasmodium falciparum genetic cross reveals the contributions of pfcrt and plasmepsin II/III to piperaquine drug resistance;mBio;2024-07-17

3. Evaluation of Dihydroartemisinin–Piperaquine Efficacy and Molecular Markers in Uncomplicated Falciparum Patients: A Study across Binh Phuoc and Dak Nong, Vietnam;Medicina;2024-06-20

4. Incomplete Plasmodium falciparum growth inhibition following piperaquine treatment translates into increased parasite viability in the in vitro parasite reduction ratio assay;Frontiers in Cellular and Infection Microbiology;2024-04-30

5. Ex vivo drug susceptibility and resistance mediating genetic polymorphisms of Plasmodium falciparum in Bobo-Dioulasso, Burkina Faso;Antimicrobial Agents and Chemotherapy;2024-04-03